New & Noteworthy

March 2022

Collaboration to Enhance Controlled Substance Management

Omnicell, Inc

Omnicell, Inc and Fresenius Kabi are collaborating to provide health systems with new pharmacy technology designed to support safety and efficiency in dispensing of controlled substances in patient care areas. This collaboration brings together Omnicell’s Controlled Substance Dispenser (CSD), a high-volume, automated single dose dispensing solution designed to help manage controlled substances, reduce diversion, and save nursing time. By providing only one dose at a time, the CSD is designed to eliminate the need for countbacks and decrease the time required to resolve medication discrepancies. New cassettes for the CSD have been designed specifically for Fresenius Kabi Simplist MicroVault prefilled syringes to provide more flexibility to the medication supply chain and enhanced controlled substance management initiatives. The new cassettes will accommodate MicroVault packaging for a variety of low-dose narcotic medications including morphine, hydromorphone, and fentanyl. The syringes are manufacturer-prepared in the US, with a 24-month shelf life, and are single-unit doses, supporting best practices for medication administration.

Request More Information

Current Issue